A National Technical Working Group established by the Ghana Health Service (GHS) is currently assessing the possibility of deploying COVID-19 vaccines in the country. The Technical Group has identified vaccines manufactured by Pfizer with 98 per cent and Modena with 94 percent efficacy levels, as possible ones to be deployed into the country though about 10 vaccines were at different stages of development globally.
Dr Patrick Kumah-Aboagye, the Director-General of the GHS, who announced this in Accra, on Wednesday at the Coronavirus Update, said the Technical Working Group was assessing the country's logistical needs and deployment plan for the vaccines. The GHS Boss failed to state the exact time the vaccines would be deployed in Ghana but indicated that other countries would start using the vaccines this month.
Currently, he said, Ghana's COVID-19 active cases stood at 775 as of November 24, 2020, declining by about 500 cases recorded in October.
Dr Kumah-Aboagye said the country's cumulative cases stood at 51,233 with 50,127 discharged with 323 deaths, representing over 95 percent recovery rate.
The active cases were fairly distributed across the regions including the Greater Accra, Ashanti, Bono, Western, Eastern, and Central.